Trial Outcomes & Findings for MR Fingerprinting: A Novel Sequence Applied to Neuroimaging (NCT NCT03800537)
NCT ID: NCT03800537
Last Updated: 2023-06-12
Results Overview
Magnetic Resonance (MR) fingerprinting sequences will be examined to determine their utility for visualizing pathology.
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
14 participants
Primary outcome timeframe
Immediately following MRI completion, within approximately 5 minutes
Results posted on
2023-06-12
Participant Flow
Participant milestones
| Measure |
All Participants
All participants will receive the investigational MR Fingerprinting sequence.
MR Fingerprinting: The MR fingerprinting technique requires less than 15 minutes and will be added following the standard MRI sequence.
|
|---|---|
|
Overall Study
STARTED
|
14
|
|
Overall Study
COMPLETED
|
10
|
|
Overall Study
NOT COMPLETED
|
4
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
MR Fingerprinting: A Novel Sequence Applied to Neuroimaging
Baseline characteristics by cohort
| Measure |
All Participants
n=14 Participants
All participants will receive the investigational MR Fingerprinting sequence.
MR Fingerprinting: The MR fingerprinting technique requires less than 15 minutes and will be added following the standard MRI sequence.
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
12 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
2 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
11 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
3 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
0 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
14 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
4 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
10 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
14 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Immediately following MRI completion, within approximately 5 minutesMagnetic Resonance (MR) fingerprinting sequences will be examined to determine their utility for visualizing pathology.
Outcome measures
| Measure |
All Participants
n=10 Participants
All participants will receive the investigational MR Fingerprinting sequence.
MR Fingerprinting: The MR fingerprinting technique requires less than 15 minutes and will be added following the standard MRI sequence.
|
|---|---|
|
Percent of Participants With Visible Region of Interest (Imaging Visibility)
|
100 percentage of participants
|
Adverse Events
All Participants
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Desma Jones
University of North Carolina at Chapel Hill
Phone: 919-843-9463
Email: [email protected]
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place